Medical Editorial Policy
South Florida Trim Clinic is a healthcare website subject to the highest standards of accuracy, transparency, and medical integrity. This page explains exactly how we create, review, and maintain our clinical content.
Last reviewed: July 2026
Editorial Independence
South Florida Trim Clinic's editorial content is independent from our commercial operations. Clinical information is not influenced by marketing objectives, medication availability, or business considerations. No advertiser, sponsor, or commercial partner controls or influences our medical content.
Our revenue comes exclusively from telehealth medical weight loss services provided to enrolled patients. We do not accept payment for editorial coverage, sponsored clinical articles, or paid mentions of medications or brands.
Our Medical Editorial Team
Medical and clinical content on this website is reviewed by licensed medical providers who practice at South Florida Trim Clinic. All reviewing providers hold active licenses in their respective states and maintain current knowledge in obesity medicine, GLP-1 pharmacotherapy, and telehealth delivery of care.
Full provider credentials, biographies, and license information are disclosed to enrolled patients at the time of consultation. Individual provider attribution on public-facing educational content is pending clinical staff approval and will be updated on an ongoing basis.
Provider Attribution Status (July 2026): Clinical content is reviewed by licensed providers. Named individual attribution is being implemented and will appear on each medical page as provider consent is confirmed. This process is standard practice for HIPAA-compliant healthcare websites.
Clinical Content Standards
- All medical claims must be supported by FDA prescribing information, peer-reviewed research, or guidance from recognized medical organizations such as the Obesity Medicine Association or The Endocrine Society.
- Content must not make unsupported outcome claims. Phrases like 'guaranteed results,' 'will cause weight loss,' or 'cures obesity' are prohibited.
- Eligibility criteria, contraindications, side effects, and risks must be clearly disclosed on every clinical page.
- Medications are referred to by their generic name (semaglutide, tirzepatide) with brand names (Wegovy®, Ozempic®, Zepbound®, Mounjaro®) noted parenthetically where helpful.
- Content must not promote off-label uses without clear disclosure.
- All statistical claims (e.g., weight loss percentages cited from clinical trials) must be attributed to their source and accompanied by appropriate context including trial population and limitations.
- Content is written at a level accessible to a general adult reader without specialized medical knowledge.
- Clinical pages include a 'Last reviewed' date reflecting the most recent medical review.
Research & Citation Policy
South Florida Trim Clinic cites authoritative, publicly verifiable sources for clinical claims. We prioritize sources in this order:
- FDA prescribing information and approval announcements — for indications, dosing, contraindications, and safety data
- Peer-reviewed clinical trials — published in journals such as the New England Journal of Medicine, JAMA, Diabetes Care, and Obesity
- NIH and NIDDK resources — for epidemiological data and public health guidance
- Major medical organization guidelines — including the Obesity Medicine Association, The Endocrine Society, and the American Diabetes Association
- Systematic reviews and meta-analyses — from recognized databases including PubMed and Cochrane
We do not use press releases, commercial websites, or non-peer-reviewed sources as the basis for clinical claims. Wikipedia, patient forums, and company websites are not considered authoritative sources for medical content.
Content Review Process
Each piece of clinical content on this website follows a defined review cycle:
Corrections Policy
South Florida Trim Clinic is committed to correcting errors promptly and transparently. If you believe any information on this website is factually inaccurate, out of date, or clinically misleading, please contact us.
Upon receiving a correction request:
- We will review the claim and consult authoritative sources within 5 business days.
- If an error is confirmed, we will correct it promptly and update the page's 'Last reviewed' date.
- Material corrections will include a correction notice at the bottom of the affected page.
- We will not delete accurate content simply because it is unflattering to a commercial interest.
Advertising & Sponsorship Disclosure
South Florida Trim Clinic does not accept advertising, sponsorships, or paid placements on medical or educational content pages. We are not affiliated with, sponsored by, or paid by the manufacturers of semaglutide (Novo Nordisk), tirzepatide (Eli Lilly), or any other pharmaceutical company.
Brand names (Ozempic®, Wegovy®, Mounjaro®, Zepbound®) are referenced for educational identification purposes only. Their mention does not imply any commercial relationship or endorsement.
See our full Advertising & Sponsorship Disclosure page.
Contact Our Editorial Team
To submit a correction request, report a factual error, or raise a concern about any clinical content on this website, contact us at:
info@southfloridatrimclinic.comPlease include the page URL, the specific statement you believe is inaccurate, and any supporting sources. We respond to all correction requests within 5 business days.
Related policies: Privacy Policy · Terms & Conditions · Accessibility Statement · Advertising Disclosure · HIPAA & Telehealth Privacy
